让国产糖尿病治疗药物站上更大舞台

吉林日报
Jul 07, 2025

位于梅河口市的惠升生物制药股份有限公司是四环医药集团的控股子公司。该公司研发上市的脯氨酸加格列净片是吉林省近五年内唯一获批的化药1类创新药。同时,惠升生物也是继进口原研药企之后国内首家且唯一一家完成德谷门冬双胰岛素注射液上市批准的企业。糖尿病是全球最重要的健康问题之一,四环医药集团从2014年起前瞻性地布局糖尿病治疗领域,创建了专注于该治疗领域,集产销研为一体的惠升生物。历经十余年的持续发展,该...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10